Bausch Health Companies Inc.
- Stock
- Ticker BHC
- ISIN CA0717341071
- NYSE
- US listing in dollars
Performance, volatility and drawdowns of Bausch Health Companies Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $4,480. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −87.4% in 04/2025, measured from the peak in 03/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,559 | 2,259 | 2,530 | 2,681 | 2,796 | 2,524 | 2,852 | 2,941 |
| Operating income | 558 | 276 | 444 | 619 | 474 | -950 | 740 | 983 |
| EBITDA | 865 | 581 | 751 | 925 | 764 | -655 | 1,021 | 1,267 |
| Net income | 93 | -58 | 148 | 179 | -112 | -1,423 | 258 | 436 |
| Earnings per share | 0.25 | -0.16 | 0.40 | 0.48 | -0.30 | -3.82 | 0.68 | 1.15 |
| Balance sheet | ||||||||
| Total assets | 26,523 | 26,421 | 27,266 | 26,824 | 26,366 | 24,498 | 24,794 | 25,484 |
| Liabilities | 26,845 | 26,661 | 27,119 | 26,468 | 25,989 | 25,580 | 25,596 | 25,825 |
| Equity | -1,279 | -1,183 | -764 | -565 | -554 | -2,059 | -1,771 | -1,328 |
| Cash | 1,181 | 1,134 | 1,727 | 1,308 | 1,309 | 1,299 | 1,825 | 2,485 |
| Long-term debt | 18,942 | 21,228 | 20,859 | 20,463 | 20,592 | 19,875 | 19,875 | 19,771 |
| Cash flow | ||||||||
| Operating cash flow | 601 | 211 | 289 | 405 | 495 | 230 | 670 | 814 |
| Capital expenditure | -106 | -115 | -99 | -91 | -92 | -109 | -77 | -66 |
| Free cash flow | 495 | 96 | 190 | 314 | 403 | 121 | 593 | 748 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +62.0%, weakest 2022 at −77.3%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $1.15 |
| 30 Jul 2026 | $0.68 |
| 30 Apr 2026 | −$3.82 |
| 19 Feb 2026 | −$0.30 |
| 30 Oct 2025 | $0.48 |
| 31 Jul 2025 | $0.40 |
| 1 May 2025 | −$0.16 |
| 20 Feb 2025 | $0.25 |
| 31 Oct 2024 | −$0.23 |
| 1 Aug 2024 | $0.03 |
| 2 May 2024 | −$0.17 |
| 22 Feb 2024 | −$0.10 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.8bn
- Market cap in trading currency
- $3.08bn
- Enterprise value
- $21.2bn
- P/E
- –
- P/S
- 0.28
- P/B
- –
- EV/Sales
- 1.91
- EV/EBITDA
- 8.9
- Earnings yield
- –
- FCF yield
- 60.6%
Results (last four quarters)
- Revenue
- $11.1bn
- Gross profit
- –
- EBITDA
- $2.40bn
- Net income
- −$841m
- Earnings per share
- −$2.29
- Revenue per share
- $29.69
- Revenue growth
- +9.7%
- Earnings growth
- +143.6%
Profitability
- Gross margin
- –
- Operating margin
- 11.2%
- Net margin
- -7.6%
- Return on equity
- –
- Return on assets
- -3.3%
Balance sheet and cash flow
- Cash
- $2.49bn
- Cash per share
- $6.64
- Financial debt
- $20.6bn
- Debt/equity %
- –
- Current ratio
- 1.56
- Book value per share
- −$3.55
- Operating cash flow
- $2.21bn
- Free cash flow
- $1.87bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 374m
- Volume
- 3.75m
- Avg. volume 3 months
- 3.10m
- Relative volume
- 1.2
Price and technicals
- Price
- $8.22
- 1 day
- −4.0%
- 52-week high
- $8.91
- 52-week low
- $4.43
- Distance to 52-week high
- −7.7%
- Distance to 52-week low
- +85.6%
- Distance to 50-day line
- +20.9%
- Distance to 200-day line
- +40.1%
- RSI (14)
- 59
- Volatility 1M
- 103.7%
Performance
- 1 week
- −1.6%
- 1 month
- +26.7%
- 3 months
- +23.1%
- 6 months
- +50.3%
- YTD
- +18.3%
- 1 year
- +35.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has BHC performed since 11/2016?
$10,000 grew to $4,480 by 20 Nov 2026, which is −7.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is BHC?
Volatility was 59.4% per year, measured on monthly returns. The largest decline from a peak was −87.4%, with the low in 04/2025.
How does BHC compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BHC returned −7.7% at 59.4%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.